Eurofins Scientific SE (ERF.PA)
EUR 56.58
(1.98%)
EUR 56.58
(1.98%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.92 Billion EUR | 48.15% |
| 2022 | 3.32 Billion EUR | 20.75% |
| 2021 | 2.75 Billion EUR | -12.7% |
| 2020 | 3.15 Billion EUR | -10.93% |
| 2019 | 3.54 Billion EUR | 12.18% |
| 2018 | 3.15 Billion EUR | 42.45% |
| 2017 | 2.21 Billion EUR | 60.15% |
| 2016 | 1.38 Billion EUR | -19.07% |
| 2015 | 1.71 Billion EUR | 140.77% |
| 2014 | 710.23 Million EUR | 3.82% |
| 2013 | 684.1 Million EUR | 57.22% |
| 2012 | 435.11 Million EUR | 0.1% |
| 2011 | 434.67 Million EUR | 57.08% |
| 2010 | 276.71 Million EUR | 130.56% |
| 2009 | 120.01 Million EUR | -58.58% |
| 2008 | 289.73 Million EUR | 694.23% |
| 2007 | 36.48 Million EUR | -38.21% |
| 2006 | 59.03 Million EUR | -41.82% |
| 2005 | 101.47 Million EUR | 59.65% |
| 2004 | 63.55 Million EUR | 38.25% |
| 2003 | 45.97 Million EUR | -10.69% |
| 2002 | 51.47 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.39 Billion EUR | -31.05% |
| 2024 Q2 | 3.39 Billion EUR | 0.0% |
| 2023 Q2 | 3.27 Billion EUR | 4.2% |
| 2023 Q3 | 3.78 Billion EUR | 15.56% |
| 2023 FY | 4.92 Billion EUR | 48.15% |
| 2023 Q4 | 4.92 Billion EUR | 30.2% |
| 2023 Q1 | 3.14 Billion EUR | -5.5% |
| 2022 Q2 | 3.34 Billion EUR | 4.0% |
| 2022 Q1 | 3.21 Billion EUR | 16.81% |
| 2022 FY | 3.32 Billion EUR | 20.75% |
| 2022 Q4 | 3.32 Billion EUR | 4.02% |
| 2022 Q3 | 3.19 Billion EUR | -4.45% |
| 2021 Q4 | 2.75 Billion EUR | 4.58% |
| 2021 Q3 | 2.63 Billion EUR | -0.81% |
| 2021 FY | 2.75 Billion EUR | -12.7% |
| 2021 Q2 | 2.65 Billion EUR | 0.0% |
| 2021 Q1 | 2.65 Billion EUR | -15.84% |
| 2020 Q4 | 3.15 Billion EUR | 3.91% |
| 2020 Q3 | 3.03 Billion EUR | -5.11% |
| 2020 FY | 3.15 Billion EUR | -10.93% |
| 2020 Q1 | 3.19 Billion EUR | -9.66% |
| 2020 Q2 | 3.19 Billion EUR | 0.0% |
| 2019 Q2 | 3.54 Billion EUR | 0.0% |
| 2019 Q3 | 3.41 Billion EUR | -3.73% |
| 2019 Q1 | 3.54 Billion EUR | 12.31% |
| 2019 FY | 3.54 Billion EUR | 12.18% |
| 2019 Q4 | 3.54 Billion EUR | 3.75% |
| 2018 Q4 | 3.15 Billion EUR | 0.29% |
| 2018 FY | 3.15 Billion EUR | 42.45% |
| 2018 Q1 | 2.19 Billion EUR | -0.83% |
| 2018 Q2 | 2.19 Billion EUR | 0.0% |
| 2018 Q3 | 3.14 Billion EUR | 43.23% |
| 2017 Q4 | 2.21 Billion EUR | 0.29% |
| 2017 Q3 | 2.2 Billion EUR | 65.68% |
| 2017 Q2 | 1.33 Billion EUR | -0.03% |
| 2017 FY | 2.21 Billion EUR | 60.15% |
| 2017 Q1 | 1.33 Billion EUR | -3.58% |
| 2016 Q4 | 1.38 Billion EUR | 0.29% |
| 2016 Q2 | 1.62 Billion EUR | -0.19% |
| 2016 Q1 | 1.63 Billion EUR | -4.57% |
| 2016 FY | 1.38 Billion EUR | -19.07% |
| 2016 Q3 | 1.37 Billion EUR | -15.29% |
| 2015 FY | 1.71 Billion EUR | 140.77% |
| 2015 Q4 | 1.71 Billion EUR | -0.02% |
| 2015 Q3 | 1.71 Billion EUR | 48.6% |
| 2015 Q2 | 1.15 Billion EUR | -0.8% |
| 2015 Q1 | 1.16 Billion EUR | 63.36% |
| 2014 Q2 | 864.1 Million EUR | -1.66% |
| 2014 Q3 | 719.74 Million EUR | -16.71% |
| 2014 Q4 | 710.23 Million EUR | -1.32% |
| 2014 FY | 710.23 Million EUR | 3.82% |
| 2014 Q1 | 878.71 Million EUR | 28.45% |
| 2013 Q1 | 515.1 Million EUR | 18.38% |
| 2013 Q2 | 498.99 Million EUR | -3.13% |
| 2013 Q4 | 684.1 Million EUR | -1.58% |
| 2013 Q3 | 695.06 Million EUR | 39.29% |
| 2013 FY | 684.1 Million EUR | 57.22% |
| 2012 Q2 | 432.13 Million EUR | 297.26% |
| 2012 FY | 435.11 Million EUR | 0.1% |
| 2012 Q3 | 108.77 Million EUR | -74.83% |
| 2012 Q4 | 435.11 Million EUR | 300.0% |
| 2012 Q1 | 108.77 Million EUR | -74.97% |
| 2011 Q3 | 419.46 Million EUR | 19.13% |
| 2011 Q1 | 360.04 Million EUR | 30.11% |
| 2011 Q2 | 352.1 Million EUR | -2.2% |
| 2011 Q4 | 434.67 Million EUR | 3.63% |
| 2011 FY | 434.67 Million EUR | 57.08% |
| 2010 Q2 | 131.45 Million EUR | -44.8% |
| 2010 FY | 276.71 Million EUR | 130.56% |
| 2010 Q3 | 302.02 Million EUR | 129.75% |
| 2010 Q4 | 276.71 Million EUR | -8.38% |
| 2010 Q1 | 238.12 Million EUR | 98.41% |
| 2009 FY | 120.01 Million EUR | -58.58% |
| 2009 Q4 | 120.01 Million EUR | 300.0% |
| 2009 Q2 | 30 Million EUR | 0.0% |
| 2009 Q1 | 30 Million EUR | -58.58% |
| 2009 Q3 | 30 Million EUR | 0.0% |
| 2008 Q4 | 72.43 Million EUR | 0.0% |
| 2008 Q1 | 72.43 Million EUR | 694.23% |
| 2008 Q3 | 72.43 Million EUR | 0.0% |
| 2008 FY | 289.73 Million EUR | 694.23% |
| 2008 Q2 | 72.43 Million EUR | 0.0% |
| 2007 Q3 | 9.12 Million EUR | 0.0% |
| 2007 Q2 | 9.12 Million EUR | 0.0% |
| 2007 Q4 | 9.12 Million EUR | 0.0% |
| 2007 Q1 | 9.12 Million EUR | -38.21% |
| 2007 FY | 36.48 Million EUR | -38.21% |
| 2006 Q4 | 14.75 Million EUR | 0.0% |
| 2006 Q3 | 14.75 Million EUR | 0.0% |
| 2006 Q2 | 14.75 Million EUR | 0.0% |
| 2006 FY | 59.03 Million EUR | -41.82% |
| 2006 Q1 | 14.75 Million EUR | -41.82% |
| 2005 Q4 | 25.36 Million EUR | 0.0% |
| 2005 Q3 | 25.36 Million EUR | 0.0% |
| 2005 Q2 | 25.36 Million EUR | 0.0% |
| 2005 Q1 | 25.36 Million EUR | 59.65% |
| 2005 FY | 101.47 Million EUR | 59.65% |
| 2004 Q3 | 15.88 Million EUR | 0.0% |
| 2004 Q4 | 15.88 Million EUR | 0.0% |
| 2004 Q2 | 15.88 Million EUR | 0.0% |
| 2004 Q1 | 15.88 Million EUR | 38.25% |
| 2004 FY | 63.55 Million EUR | 38.25% |
| 2003 Q3 | 11.49 Million EUR | 0.0% |
| 2003 Q4 | 11.49 Million EUR | 0.0% |
| 2003 FY | 45.97 Million EUR | -10.69% |
| 2003 Q2 | 11.49 Million EUR | 0.0% |
| 2003 Q1 | 11.49 Million EUR | -10.69% |
| 2002 Q1 | 12.86 Million EUR | 0.0% |
| 2002 Q4 | 12.86 Million EUR | 0.0% |
| 2002 FY | 51.47 Million EUR | 0.0% |
| 2002 Q3 | 12.86 Million EUR | 0.0% |
| 2002 Q2 | 12.86 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Biosynex SA | 65.59 Million EUR | -7410.442% |
| Predilife S.A. | 7.18 Million EUR | -68495.859% |
| bioMérieux S.A. | 518.79 Million EUR | -849.634% |
| Lumibird SA | 145.07 Million EUR | -3295.921% |